<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="protocol"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-id journal-id-type="hwp">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22389363</article-id><article-id pub-id-type="pmc">3293141</article-id><article-id pub-id-type="publisher-id">bmjopen-2012-000813</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2012-000813</article-id><article-categories><subj-group subj-group-type="heading"><subject>Intensive Care</subject><subj-group><subject>Protocol</subject></subj-group></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1707</subject><subject>1731</subject><subject>1736</subject></subj-group></article-categories><title-group><article-title>Protocol: inspiratory muscle training for promoting recovery and outcomes in ventilated patients (IMPROVe): a randomised controlled trial</article-title><alt-title alt-title-type="short">Protocol: inspiratory muscle training for ventilated patients (RCT)</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Bissett</surname><given-names>Bernie M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Leditschke</surname><given-names>I Anne</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Paratz</surname><given-names>Jennifer D</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Boots</surname><given-names>Robert J</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Physiotherapy Department, Canberra Hospital, Canberra, Australian Capital Territory, Australia</aff><aff id="aff2"><label>2</label>School of Medicine, University of Queensland, Brisbane, Queensland, Australia</aff><aff id="aff3"><label>3</label>Intensive Care Unit, Canberra Hospital, Canberra, Australian Capital Territory, Australia</aff><aff id="aff4"><label>4</label>School of Medicine, Australian National University, Canberra, Australian Capital Territory, Australia</aff><aff id="aff5"><label>5</label>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia</aff><aff id="aff6"><label>6</label>Burns, Trauma &amp; Critical Care Research Centre, University of Queensland, School of Medicine, Brisbane, Queensland, Australia</aff><author-notes><corresp><bold>Correspondence to</bold> Bernie M Bissett; <email>bernie.bissett@act.gov.au</email></corresp></author-notes><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>2</day><month>3</month><year>2012</year></pub-date><pub-date pub-type="pmc-release"><day>2</day><month>3</month><year>2012</year></pub-date><volume>2</volume><issue>2</issue><elocation-id>e000813</elocation-id><history><date date-type="received"><day>4</day><month>1</month><year>2012</year></date><date date-type="accepted"><day>6</day><month>2</month><year>2012</year></date></history><permissions><copyright-statement>© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/">http://creativecommons.org/licenses/by-nc/2.0/</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/legalcode">http://creativecommons.org/licenses/by-nc/2.0/legalcode</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="bmjopen-2012-000813.pdf"></self-uri><self-uri content-type="draft-revisions-pdf" xlink:type="simple" xlink:href="bmjopen-2012-000813.draft_revisions.pdf"></self-uri><self-uri content-type="reviewers-comments-pdf" xlink:type="simple" xlink:href="bmjopen-2012-000813.reviewer_comments.pdf"></self-uri><abstract><sec><title><offsets xml_i="5122" xml_f="5134" txt_i="11" txt_f="23">Introduction</offsets></title><p><offsets xml_i="5145" xml_f="5609" txt_i="24" txt_f="488">Inspiratory muscle weakness is a known consequence of mechanical ventilation and a potential contributor to difficulty in weaning from ventilatory support. Inspiratory muscle training (IMT) reduces the weaning period and increases the likelihood of successful weaning in some patients. However, it is not known how this training affects the residual inspiratory muscle fatigability following successful weaning nor patients' quality of life or functional outcomes.</offsets></p></sec><sec><title><offsets xml_i="5631" xml_f="5651" txt_i="490" txt_f="510">Methods and analysis</offsets></title><p><offsets xml_i="5662" xml_f="6550" txt_i="511" txt_f="1393">This dual centre study includes two concurrent randomised controlled trials of IMT in adult patients who are either currently ventilator-dependent (&gt;7 days) (n=70) or have been recently weaned from mechanical ventilation (&gt;7 days) in the past week (n=70). Subjects will be stable, alert and able to actively participate and provide consent. There will be concealed allocation to either treatment (IMT) or usual physiotherapy (including deep breathing exercises without a resistance device). Primary outcomes are inspiratory muscle fatigue resistance and maximum inspiratory pressures. Secondary outcomes are quality of life (Short Form-36v2, EQ-5D), functional status (Acute Care Index of Function), rate of perceived exertion (Borg Scale), intensive care length of stay (days), post intensive care length of stay (days), rate of reintubation (%) and duration of ventilation (days).</offsets></p></sec><sec><title><offsets xml_i="6572" xml_f="6596" txt_i="1395" txt_f="1419">Ethics and dissemination</offsets></title><p><offsets xml_i="6607" xml_f="6869" txt_i="1420" txt_f="1682">Ethics approval has been obtained from relevant institutions, and results will be published with a view to influencing physiotherapy practice in the management of long-term ventilator-dependent patients to accelerate weaning and optimise rehabilitation outcomes.</offsets></p></sec><sec><title><offsets xml_i="6891" xml_f="6916" txt_i="1684" txt_f="1709">Trial registration number</offsets></title><p><offsets xml_i="6927" xml_f="6947" txt_i="1710" txt_f="1730">ACTRN12610001089022.</offsets></p></sec></abstract><abstract abstract-type="summary"><title><offsets xml_i="7009" xml_f="7024" txt_i="1743" txt_f="1758">Article summary</offsets></title><sec><title><offsets xml_i="7044" xml_f="7057" txt_i="1759" txt_f="1772">Article focus</offsets></title><list list-type="bullet"><list-item><p><offsets xml_i="7104" xml_f="7245" txt_i="1773" txt_f="1914">Mechanical ventilation (MV) is known to cause inspiratory muscle weakness, which may contribute to both difficulty weaning and poor recovery.</offsets></p></list-item><list-item><p><offsets xml_i="7275" xml_f="7363" txt_i="1915" txt_f="2003">Can IMT hasten weaning and enhance recovery from MV if commenced while still ventilated?</offsets></p></list-item><list-item><p><offsets xml_i="7393" xml_f="7457" txt_i="2004" txt_f="2068">Can IMT enhance recovery if commenced following weaning from MV?</offsets></p></list-item></list></sec><sec><title><offsets xml_i="7498" xml_f="7510" txt_i="2070" txt_f="2082">Key messages</offsets></title><list list-type="bullet"><list-item><p><offsets xml_i="7557" xml_f="7736" txt_i="2083" txt_f="2262">This protocol outlines two concurrent randomised controlled trials that investigate the effects of IMT as a component of early rehabilitation in an Australian intensive care unit.</offsets></p></list-item><list-item><p><offsets xml_i="7766" xml_f="7895" txt_i="2263" txt_f="2392">The study is designed to capture both physiological measures as well as patient-centred measures of function and quality of life.</offsets></p></list-item></list></sec><sec><title><offsets xml_i="7936" xml_f="7975" txt_i="2394" txt_f="2433">Strengths and limitations of this study</offsets></title><list list-type="bullet"><list-item><p><offsets xml_i="8022" xml_f="8161" txt_i="2434" txt_f="2573">This study is the first of its kind to focus on patient-centred measures and longer term outcomes beyond the period of ventilatory weaning.</offsets></p></list-item><list-item><p><offsets xml_i="8191" xml_f="8357" txt_i="2574" txt_f="2740">The results of this study will not be generalisable to some intensive care units, which generally keep patients sedated, as patient alertness is a requirement of IMT.</offsets></p></list-item></list></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="8438" xml_f="8448" txt_i="2749" txt_f="2759">Background</offsets></title><p><offsets xml_i="8459" xml_f="8658" txt_i="2760" txt_f="2959">Mechanical ventilation (MV) used in intensive care units (ICUs), while often essential in the management of respiratory failure, can result in respiratory dysfunction and inspiratory muscle weakness.</offsets><xref ref-type="bibr" rid="b1"><offsets xml_i="8689" xml_f="8690" txt_i="2959" txt_f="2960">1</offsets></xref><offsets xml_i="8697" xml_f="8841" txt_i="2960" txt_f="3104"> Even patients who can successfully wean from MV may suffer impaired fatigue resistance of the inspiratory muscles following successful weaning.</offsets><xref ref-type="bibr" rid="b2"><offsets xml_i="8872" xml_f="8873" txt_i="3104" txt_f="3105">2</offsets></xref><offsets xml_i="8880" xml_f="8961" txt_i="3105" txt_f="3186"> Inspiratory muscle weakness has been associated with difficulty weaning from MV,</offsets><xref ref-type="bibr" rid="b3"><offsets xml_i="8992" xml_f="8993" txt_i="3186" txt_f="3187">3</offsets></xref><offsets xml_i="9000" xml_f="9075" txt_i="3187" txt_f="3262"> and the degree of weakness is correlated with the duration of ventilation.</offsets><xref ref-type="bibr" rid="b2"><offsets xml_i="9106" xml_f="9107" txt_i="3262" txt_f="3263">2</offsets></xref><offsets xml_i="9114" xml_f="9115" txt_i="3263" txt_f="3264">
</offsets><xref ref-type="bibr" rid="b3"><offsets xml_i="9146" xml_f="9147" txt_i="3264" txt_f="3265">3</offsets></xref><offsets xml_i="9154" xml_f="9309" txt_i="3265" txt_f="3420"> One case–control study demonstrated that MV results in increased proteolysis and atrophy in the diaphragm muscle, while other skeletal muscles are spared.</offsets><xref ref-type="bibr" rid="b4"><offsets xml_i="9340" xml_f="9341" txt_i="3420" txt_f="3421">4</offsets></xref><offsets xml_i="9348" xml_f="9495" txt_i="3421" txt_f="3568"> Clearly, inspiratory muscle weakness is likely to be at least one of the factors that could contribute to difficult and prolonged weaning from MV.</offsets><xref ref-type="bibr" rid="b5"><offsets xml_i="9526" xml_f="9527" txt_i="3568" txt_f="3569">5</offsets></xref></p><p><offsets xml_i="9541" xml_f="9846" txt_i="3570" txt_f="3875">Inspiratory muscle training (IMT) with a threshold device has been used in patients with chronic lung disease for many years, resulting in not just increased inspiratory muscle strength but also increased inspiratory muscle endurance, reduced dyspnoea and increased exercise tolerance and quality of life.</offsets><xref ref-type="bibr" rid="b6"><offsets xml_i="9877" xml_f="9878" txt_i="3875" txt_f="3876">6</offsets></xref><offsets xml_i="9885" xml_f="10022" txt_i="3876" txt_f="4013"> Since 2002, case reports of IMT in ventilator-dependent patients have suggested that IMT is associated with favourable weaning outcomes.</offsets><xref ref-type="bibr" rid="b7 b8 b9"><offsets xml_i="10059" xml_f="10062" txt_i="4013" txt_f="4016">7–9</offsets></xref><offsets xml_i="10069" xml_f="10106" txt_i="4016" txt_f="4053"> More recently, two randomised trials</offsets><xref ref-type="bibr" rid="b10"><offsets xml_i="10138" xml_f="10140" txt_i="4053" txt_f="4055">10</offsets></xref><offsets xml_i="10147" xml_f="10148" txt_i="4055" txt_f="4056">
</offsets><xref ref-type="bibr" rid="b11"><offsets xml_i="10180" xml_f="10182" txt_i="4056" txt_f="4058">11</offsets></xref><offsets xml_i="10189" xml_f="10362" txt_i="4058" txt_f="4231"> using different training strategies have demonstrated benefits of IMT for ventilated patients, including statistically significant increases in inspiratory muscle strength,</offsets><xref ref-type="bibr" rid="b10"><offsets xml_i="10394" xml_f="10396" txt_i="4231" txt_f="4233">10</offsets></xref><offsets xml_i="10403" xml_f="10404" txt_i="4233" txt_f="4234">
</offsets><xref ref-type="bibr" rid="b11"><offsets xml_i="10436" xml_f="10438" txt_i="4234" txt_f="4236">11</offsets></xref><offsets xml_i="10445" xml_f="10488" txt_i="4236" txt_f="4279"> reduced weaning time by a mean of 1.7 days</offsets><xref ref-type="bibr" rid="b10"><offsets xml_i="10520" xml_f="10522" txt_i="4279" txt_f="4281">10</offsets></xref><offsets xml_i="10529" xml_f="10602" txt_i="4281" txt_f="4354"> and a higher rate of successful weaning at day 28 (71% compared to 47%).</offsets><xref ref-type="bibr" rid="b11"><offsets xml_i="10634" xml_f="10636" txt_i="4354" txt_f="4356">11</offsets></xref><offsets xml_i="10643" xml_f="10753" txt_i="4356" txt_f="4466"> However, the generalisability of these results is limited by the subgroups studied (aged older than 70 years,</offsets><xref ref-type="bibr" rid="b10"><offsets xml_i="10785" xml_f="10787" txt_i="4466" txt_f="4468">10</offsets></xref><offsets xml_i="10794" xml_f="10809" txt_i="4468" txt_f="4483"> failed to wean</offsets><xref ref-type="bibr" rid="b11"><offsets xml_i="10841" xml_f="10843" txt_i="4483" txt_f="4485">11</offsets></xref><offsets xml_i="10850" xml_f="11286" txt_i="4485" txt_f="4921">) as well as the sedation and rehabilitation approaches used in the investigating centres units. It is not yet known whether similar results would apply to a more heterogeneous group of ICU patients in an Australian ICU context. For example, an approach of minimal sedation and early active rehabilitation may result in different training effects and relative benefits of IMT. It is also not known which training parameters are optimal.</offsets></p><p><offsets xml_i="11293" xml_f="11535" txt_i="4922" txt_f="5164">In an analysis of 195 IMT treatments in ventilated patients, IMT was found to be safe with zero adverse outcomes and stable physiological parameters in response to training (blood pressure, heart rate, oxygen saturation and respiratory rate).</offsets><xref ref-type="bibr" rid="b12"><offsets xml_i="11567" xml_f="11569" txt_i="5164" txt_f="5166">12</offsets></xref><offsets xml_i="11576" xml_f="11846" txt_i="5166" txt_f="5436"> However, the mechanisms of improvement with IMT in ventilated patients have not been investigated. It is theoretically feasible that a high-intensity training protocol could provide an adequate training stimulus to halt or reverse diaphragmatic atrophy and proteolysis.</offsets><xref ref-type="bibr" rid="b4"><offsets xml_i="11877" xml_f="11878" txt_i="5436" txt_f="5437">4</offsets></xref><offsets xml_i="11885" xml_f="12027" txt_i="5437" txt_f="5579"> As has been shown in athletes, IMT could also attenuate a sympathetically mediated metaboreflex, resulting in enhanced limb muscle perfusion.</offsets><xref ref-type="bibr" rid="b13"><offsets xml_i="12059" xml_f="12061" txt_i="5579" txt_f="5581">13</offsets></xref><offsets xml_i="12068" xml_f="12196" txt_i="5581" txt_f="5709"> This improved limb perfusion could facilitate early mobilisation, resulting in enhanced functional capacity or quality of life.</offsets></p><p><offsets xml_i="12203" xml_f="12502" txt_i="5710" txt_f="6009">The following protocol outlines the process by which we intend to answer some of these questions with regard to IMT in a heterogeneous group of patients who have been ventilator-dependent for 7 days or longer in our Australian ICU setting. The protocol describes two separate but concurrent studies:</offsets></p><list list-type="order"><list-item><p><offsets xml_i="12544" xml_f="12654" txt_i="6010" txt_f="6120">A randomised trial of patients who commence IMT while still ventilated (randomised controlled trial 1 (RCT1)).</offsets></p></list-item><list-item><p><offsets xml_i="12684" xml_f="12869" txt_i="6121" txt_f="6306">A randomised trial of patients who could not participate actively while ventilated but commence IMT within 1 week of successfully weaning from MV (randomised controlled trial 2 (RCT2)).</offsets></p></list-item></list><p><offsets xml_i="12895" xml_f="13038" txt_i="6307" txt_f="6450">For clarity in this protocol, ‘the study’ refers to both RCT1 and RCT2 combined. Where RCT1 and RCT2 differ, this will be described explicitly.</offsets></p></sec><sec><title><offsets xml_i="13060" xml_f="13074" txt_i="6452" txt_f="6466">RCT1: overview</offsets></title><p><offsets xml_i="13085" xml_f="13377" txt_i="6467" txt_f="6759">This trial (RCT1) examines the effects of IMT on postweaning outcomes for patients who undergo MV for at least 7 days and commence training while ventilator-dependent. This trial was registered with the Australia New Zealand Clinical Trials Registry on 13 December 2010 (ACTRN12610001089022).</offsets></p><sec><title><offsets xml_i="13393" xml_f="13397" txt_i="6760" txt_f="6764">Aims</offsets></title><p><offsets xml_i="13408" xml_f="13452" txt_i="6765" txt_f="6809">RCT1 aims to answer the following questions:</offsets></p><list list-type="order"><list-item><p><offsets xml_i="13494" xml_f="13641" txt_i="6810" txt_f="6954">Does IMT, commenced while mechanically ventilated, affect the fatigability of respiratory muscles following weaning from prolonged MV (&gt;7 days)?</offsets></p></list-item><list-item><p><offsets xml_i="13671" xml_f="13812" txt_i="6955" txt_f="7096">Does IMT, commenced while mechanically ventilated, affect the duration of ventilation required or the rate of reintubation in these patients?</offsets></p></list-item><list-item><p><offsets xml_i="13842" xml_f="13984" txt_i="7097" txt_f="7239">Is there a measurable difference in the stress response and/or anabolic response in patients undergoing IMT compared to routine physiotherapy?</offsets></p></list-item><list-item><p><offsets xml_i="14014" xml_f="14156" txt_i="7240" txt_f="7382">Does IMT affect dyspnoea, quality of life or functional measures or post-ICU length of hospital stay following successful ventilatory weaning?</offsets></p></list-item></list></sec><sec><title><offsets xml_i="14197" xml_f="14207" txt_i="7384" txt_f="7394">Hypotheses</offsets></title><p><offsets xml_i="14218" xml_f="14545" txt_i="7395" txt_f="7722">The hypotheses are that IMT will reduce inspiratory muscle fatigability, dyspnoea and possibly duration of ventilation and post-ICU length of hospital stay and will improve quality of life and functional measures in this population without concomitant increases in the stress response or detectable changes in muscle anabolism.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="14586" xml_f="14593" txt_i="7724" txt_f="7731">Methods</offsets></title><p><offsets xml_i="14604" xml_f="14709" txt_i="7732" txt_f="7837">Two RCTs will be conducted concurrently at two sites, with the anticipated flow of patients described in </offsets><xref ref-type="fig" rid="fig1"><offsets xml_i="14741" xml_f="14749" txt_i="7837" txt_f="7845">figure 1</offsets></xref><offsets xml_i="14756" xml_f="15260" txt_i="7845" txt_f="8349">. Randomisation for the study will be provided through a computer-generated random number sequence, managed off-site by clerical staff unconnected with the study and accessible to the investigators only via telephone to ensure concealed allocation. All ICU patients will be screened daily for study eligibility by the senior ICU physiotherapist. Eligible participants will be invited to participate and subsequently enrolled by the chief investigator, and baseline measures completed prior to allocation.</offsets></p><fig id="fig1" position="float"><label><offsets xml_i="15303" xml_f="15311" txt_i="8350" txt_f="8358">Figure 1</offsets></label><caption><p><offsets xml_i="15331" xml_f="15559" txt_i="8358" txt_f="8586">Flow of participants through the study. FRI, fatigue resistance index; IMT, inspiratory muscle training; MIP, maximum inspiratory pressure; QOL, quality of life; RCT, randomised controlled trial; RPE, rate of perceived exertion.</offsets></p></caption><graphic xlink:href="bmjopen-2012-000813fig1"></graphic></fig><p><offsets xml_i="15638" xml_f="16025" txt_i="8587" txt_f="8974">A total of 70 subjects will be required for RCT1. On the basis of data extrapolated from previous case series, this provides a power estimate for expected differences in fatigue resistance indices (FRI) between the groups of 0.8, if α=0.05. Sample sizes have been inflated 15% to account for the known mortality of this patient population (12.8%) (Canberra Hospital ICU Audit data 2009).</offsets></p><sec sec-type="subjects"><title><offsets xml_i="16061" xml_f="16069" txt_i="8975" txt_f="8983">Subjects</offsets></title><p><offsets xml_i="16080" xml_f="16339" txt_i="8984" txt_f="9243">Subjects will be recruited from both Canberra Hospital ICU and Calvary Hospital ICU (both located in Canberra, Australia). Patients mechanically ventilated for more than 7 days who are alert and able to co-operate with training (Riker Sedation–Agitation Score</offsets><xref ref-type="bibr" rid="b14"><offsets xml_i="16371" xml_f="16373" txt_i="9243" txt_f="9245">14</offsets></xref><offsets xml_i="16380" xml_f="16678" txt_i="9245" txt_f="9543"> of 4) and can provide informed consent will be randomised (computer-generated random number sequence, concealed allocation) to receive either IMT or usual physiotherapy care. Usual physiotherapy care typically involves deep breathing exercises (without a resistance device), manual hyperinflation,</offsets><xref ref-type="bibr" rid="b15"><offsets xml_i="16710" xml_f="16712" txt_i="9543" txt_f="9545">15</offsets></xref><offsets xml_i="16719" xml_f="16773" txt_i="9545" txt_f="9599"> secretion clearance techniques, assisted mobilisation</offsets><xref ref-type="bibr" rid="b16"><offsets xml_i="16805" xml_f="16807" txt_i="9599" txt_f="9601">16</offsets></xref><offsets xml_i="16814" xml_f="16815" txt_i="9601" txt_f="9602">
</offsets><xref ref-type="bibr" rid="b17"><offsets xml_i="16847" xml_f="16849" txt_i="9602" txt_f="9604">17</offsets></xref><offsets xml_i="16856" xml_f="16904" txt_i="9604" txt_f="9652"> and upper and lower limb exercise as indicated.</offsets></p><sec><title><offsets xml_i="16920" xml_f="16938" txt_i="9653" txt_f="9671">Inclusion criteria</offsets></title><p><offsets xml_i="16949" xml_f="16982" txt_i="9672" txt_f="9705">All patients admitted to ICU who:</offsets></p><list list-type="bullet"><list-item><p><offsets xml_i="17025" xml_f="17097" txt_i="9706" txt_f="9778">are mechanically ventilated through invasive means for 7 days or longer;</offsets></p></list-item><list-item><p><offsets xml_i="17127" xml_f="17146" txt_i="9779" txt_f="9798">are aged ≥16 years;</offsets></p></list-item><list-item><p><offsets xml_i="17176" xml_f="17242" txt_i="9799" txt_f="9865">are alert and able to co-operate with training (Riker score of 4);</offsets></p></list-item><list-item><p><offsets xml_i="17272" xml_f="17309" txt_i="9866" txt_f="9903">are able to provide informed consent;</offsets></p></list-item><list-item><p><offsets xml_i="17339" xml_f="17459" txt_i="9904" txt_f="10024">are haemodynamically stable and requiring minimal ventilatory support (ie, positive end expiratory pressure (PEEP) ≤10).</offsets></p></list-item></list></sec><sec><title><offsets xml_i="17500" xml_f="17518" txt_i="10026" txt_f="10044">Exclusion criteria</offsets></title><p><offsets xml_i="17529" xml_f="17577" txt_i="10045" txt_f="10093">Patients will be excluded from RCT1 if they are:</offsets></p><list list-type="bullet"><list-item><p><offsets xml_i="17620" xml_f="17661" txt_i="10094" txt_f="10135">undergoing non-invasive ventilation only;</offsets></p></list-item><list-item><p><offsets xml_i="17691" xml_f="17709" txt_i="10136" txt_f="10151">aged &lt;16 years;</offsets></p></list-item><list-item><p><offsets xml_i="17739" xml_f="17800" txt_i="10152" txt_f="10213">unwilling to consent or not able to provide informed consent;</offsets></p></list-item><list-item><p><offsets xml_i="17830" xml_f="17891" txt_i="10214" txt_f="10275">previously included in RCT1 (ie, patients readmitted to ICU);</offsets></p></list-item><list-item><p><offsets xml_i="17921" xml_f="17930" txt_i="10276" txt_f="10285">pregnant;</offsets></p></list-item><list-item><p><offsets xml_i="17960" xml_f="17995" txt_i="10286" txt_f="10318">mechanically ventilated &lt;7 days;</offsets></p></list-item><list-item><p><offsets xml_i="18025" xml_f="18103" txt_i="10319" txt_f="10391">not alert or able to co-operate with training (Riker score of &lt;4 or &gt;4);</offsets></p></list-item><list-item><p><offsets xml_i="18133" xml_f="18198" txt_i="10392" txt_f="10454">requiring high levels of ventilatory support (eg, PEEP &gt;10 cmH</offsets><sub><offsets xml_i="18203" xml_f="18204" txt_i="10454" txt_f="10455">2</offsets></sub><offsets xml_i="18210" xml_f="18216" txt_i="10455" txt_f="10461">O, FiO</offsets><sub><offsets xml_i="18221" xml_f="18222" txt_i="10461" txt_f="10462">2</offsets></sub><offsets xml_i="18228" xml_f="18432" txt_i="10462" txt_f="10663"> &gt;0.60, nitric oxide, nebulised prostacyclin, high frequency oscillation) and/or where the treating team (medical and/or physiotherapy) deems risks of brief disconnection from ventilation unacceptable;</offsets></p></list-item><list-item><p><offsets xml_i="18462" xml_f="18712" txt_i="10664" txt_f="10914">medically unstable (eg, new cardiac arrhythmia, acutely septic) where the treating team (medical and/or physiotherapy) considers that interference with ventilatory support could compromise patient's recovery and/or are deemed suitable for palliation;</offsets></p></list-item><list-item><p><offsets xml_i="18742" xml_f="18919" txt_i="10915" txt_f="11092">experiencing significant pain that interferes with breathing capacity (eg, fractured ribs): IMT could be reconsidered when pain is controlled and patient is able to participate.</offsets></p></list-item></list></sec></sec><sec><title><offsets xml_i="18966" xml_f="18982" txt_i="11095" txt_f="11111">Outcome measures</offsets></title><p><xref ref-type="table" rid="tbl1"><offsets xml_i="19027" xml_f="19034" txt_i="11112" txt_f="11119">Table 1</offsets></xref><offsets xml_i="19041" xml_f="19098" txt_i="11119" txt_f="11176"> provides a summary of the outcome measures used in RCT1.</offsets></p><table-wrap id="tbl1" position="float"><label><offsets xml_i="19148" xml_f="19155" txt_i="11177" txt_f="11184">Table 1</offsets></label><caption><p><offsets xml_i="19175" xml_f="19209" txt_i="11184" txt_f="11218">Outcome measures used in the study</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1"><offsets xml_i="19299" xml_f="19314" txt_i="11219" txt_f="11234">Outcome measure</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="19347" xml_f="19351" txt_i="11235" txt_f="11239">RCT1</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="19384" xml_f="19388" txt_i="11240" txt_f="11244">RCT2</offsets></td></tr></thead><tbody><tr><td rowspan="1" colspan="1"><offsets xml_i="19445" xml_f="19495" txt_i="11245" txt_f="11295">Fatigue resistance index (primary outcome measure)</offsets></td><td rowspan="1" colspan="1"><list list-type="simple"><list-item><p><offsets xml_i="19567" xml_f="19603" txt_i="11296" txt_f="11332">24 h postweaning; 7 days postweaning</offsets></p></list-item></list></td><td rowspan="1" colspan="1"><list list-type="simple"><list-item><p><offsets xml_i="19698" xml_f="19742" txt_i="11334" txt_f="11378">Commencement of training; day 14 of training</offsets></p></list-item></list></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="19807" xml_f="19835" txt_i="11380" txt_f="11408">Maximum inspiratory pressure</offsets></td><td rowspan="1" colspan="1"><list list-type="simple"><list-item><p><offsets xml_i="19907" xml_f="19969" txt_i="11409" txt_f="11471">Commencement of training; 24 h postweaning; 7 days postweaning</offsets></p></list-item></list></td><td rowspan="1" colspan="1"><list list-type="simple"><list-item><p><offsets xml_i="20064" xml_f="20108" txt_i="11473" txt_f="11517">Commencement of training; day 14 of training</offsets></p></list-item></list></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="20173" xml_f="20264" txt_i="11519" txt_f="11610">Quality of life/functional assessments (Short Form-36, EQ-5D, Acute Care Index of Function)</offsets></td><td rowspan="1" colspan="1"><list list-type="simple"><list-item><p><offsets xml_i="20336" xml_f="20380" txt_i="11611" txt_f="11655">Commencement of training; 7 days postweaning</offsets></p></list-item></list></td><td rowspan="1" colspan="1"><list list-type="simple"><list-item><p><offsets xml_i="20475" xml_f="20519" txt_i="11657" txt_f="11701">Commencement of training; day 14 of training</offsets></p></list-item></list></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="20584" xml_f="20638" txt_i="11703" txt_f="11757">Rate of perceived exertion at rest and during training</offsets></td><td rowspan="1" colspan="1"><list list-type="simple"><list-item><p><offsets xml_i="20710" xml_f="20754" txt_i="11758" txt_f="11802">Commencement of training; 7 days postweaning</offsets></p></list-item></list></td><td rowspan="1" colspan="1"><list list-type="simple"><list-item><p><offsets xml_i="20849" xml_f="20893" txt_i="11804" txt_f="11848">Commencement of training; day 14 of training</offsets></p></list-item></list></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="20958" xml_f="21092" txt_i="11850" txt_f="11984">Duration of mechanical ventilation (days) and duration of weaning (from commencement of pressure-support only to 24 h ventilator-free)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21125" xml_f="21126" txt_i="11985" txt_f="11986">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21159" xml_f="21161" txt_i="11987" txt_f="11989">NA</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="21203" xml_f="21228" txt_i="11990" txt_f="12015">ICU length of stay (days)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21261" xml_f="21262" txt_i="12016" txt_f="12017">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21295" xml_f="21297" txt_i="12018" txt_f="12020">NA</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="21339" xml_f="21457" txt_i="12021" txt_f="12139">Post-ICU discharge length of hospital stay (days) and hospital discharge destination (including in-hospital mortality)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21490" xml_f="21491" txt_i="12140" txt_f="12141">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21524" xml_f="21525" txt_i="12142" txt_f="12143">✓</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="21567" xml_f="21674" txt_i="12144" txt_f="12251">ICU readmission rates and reintubation rates (%)—defined as reintubation required within 48 h of extubation</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21707" xml_f="21708" txt_i="12252" txt_f="12253">✓</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21741" xml_f="21742" txt_i="12254" txt_f="12255">✓</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="21784" xml_f="21828" txt_i="12256" txt_f="12300">Urinary cortisol, creatinine and urea levels</offsets></td><td rowspan="1" colspan="1"><list list-type="simple"><list-item><p><offsets xml_i="21900" xml_f="21943" txt_i="12301" txt_f="12344">Commencement of training; day 7 of training</offsets></p></list-item></list></td><td rowspan="1" colspan="1"><offsets xml_i="21999" xml_f="22001" txt_i="12346" txt_f="12348">NA</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="22051" xml_f="22130" txt_i="12349" txt_f="12428">ICU, intensive care unit; NA, not applicable; RCT, randomised controlled trial.</offsets></p></fn></table-wrap-foot></table-wrap></sec></sec><sec><title><offsets xml_i="22194" xml_f="22227" txt_i="12431" txt_f="12464">Interventions, samples and assays</offsets></title><sec><title><offsets xml_i="22247" xml_f="22261" txt_i="12465" txt_f="12479">Muscle trainer</offsets></title><p><offsets xml_i="22272" xml_f="22508" txt_i="12480" txt_f="12716">IMT will be performed using the Threshold IMT inspiratory muscle trainer (Threshold IMT device HS730; Respironics, Parsippany, New Jersey, USA). This device has been validated in both healthy patients and those with chronic lung disease</offsets><xref ref-type="bibr" rid="b18"><offsets xml_i="22540" xml_f="22542" txt_i="12716" txt_f="12718">18</offsets></xref><offsets xml_i="22549" xml_f="22708" txt_i="12718" txt_f="12877"> and is superior to alternative flow resistance devices due to its reliability in ensuring prescribed pressures are achieved regardless of subject's flow rate.</offsets><xref ref-type="bibr" rid="b18"><offsets xml_i="22740" xml_f="22742" txt_i="12877" txt_f="12879">18</offsets></xref></p><p><offsets xml_i="22756" xml_f="22826" txt_i="12880" txt_f="12950">The training parameters are based on previously published case studies</offsets><xref ref-type="bibr" rid="b7 b8 b9"><offsets xml_i="22863" xml_f="22866" txt_i="12950" txt_f="12953">7–9</offsets></xref><offsets xml_i="22873" xml_f="22975" txt_i="12953" txt_f="13055"> and are consistent with evidence-based IMT training guidelines in patients with chronic lung disease,</offsets><xref ref-type="bibr" rid="b19"><offsets xml_i="23007" xml_f="23009" txt_i="13055" txt_f="13057">19</offsets></xref><offsets xml_i="23016" xml_f="23112" txt_i="13057" txt_f="13153"> which recommend that high-intensity interval training is well tolerated and optimises outcomes.</offsets><xref ref-type="bibr" rid="b20"><offsets xml_i="23144" xml_f="23146" txt_i="13153" txt_f="13155">20</offsets></xref><offsets xml_i="23153" xml_f="23299" txt_i="13155" txt_f="13301"> The physiotherapist prescribes the highest tolerable intensity that allows the subject to just complete the sixth breath in a set of six breaths.</offsets><xref ref-type="bibr" rid="b11"><offsets xml_i="23331" xml_f="23333" txt_i="13301" txt_f="13303">11</offsets></xref><offsets xml_i="23340" xml_f="23995" txt_i="13303" txt_f="13952"> The intensity is gradually increased by the physiotherapist across the training period to provide adequate training stimulus. Training is performed daily on weekdays, with the physiotherapist assisting the patient to perform five sets of six breaths each session. Between sets, patients are returned to the ventilator for a rest period as required (typically &lt;60 s). The whole training session takes &lt;10 min per day. Training will be provided by the chief investigator, senior ICU physiotherapist or a physiotherapy department staff member who has been trained and credentialed in the technique in accordance with our previously published protocol.</offsets><xref ref-type="bibr" rid="b9"><offsets xml_i="24026" xml_f="24027" txt_i="13952" txt_f="13953">9</offsets></xref></p></sec><sec><title><offsets xml_i="24056" xml_f="24100" txt_i="13955" txt_f="13999">Respiratory strength and fatigue measurement</offsets></title><p><offsets xml_i="24111" xml_f="24303" txt_i="14000" txt_f="14192">Inspiratory muscle strength will be measured as maximum inspiratory pressure (MIP), in accordance with the protocol described by the American Thoracic Society and European Respiratory Society.</offsets><xref ref-type="bibr" rid="b21"><offsets xml_i="24335" xml_f="24337" txt_i="14192" txt_f="14194">21</offsets></xref><offsets xml_i="24344" xml_f="24747" txt_i="14194" txt_f="14594"> Briefly, this technique requires the patient to maximally inhale from residual volume into a handheld pressure manometer and sustain the effort for more than 1 s. Noseclips are not required. The patient is coached to ensure adequate lip seal around the mouth piece and achieve maximum voluntary effort, and the effort is repeated until at least three measurements have &lt;20% variability between them.</offsets><xref ref-type="bibr" rid="b21"><offsets xml_i="24779" xml_f="24781" txt_i="14594" txt_f="14596">21</offsets></xref></p><p><offsets xml_i="24795" xml_f="25044" txt_i="14597" txt_f="14846">The device used to perform MIP testing is a portable MicroRPM Respiratory Pressure meter (CareFusion, San Diego, CA, USA) (Australian Therapeutic Goods Administration approval 166760). Such handheld devices have demonstrated reliability and validity</offsets><xref ref-type="bibr" rid="b22"><offsets xml_i="25076" xml_f="25078" txt_i="14846" txt_f="14848">22</offsets></xref><offsets xml_i="25085" xml_f="25215" txt_i="14848" txt_f="14978"> and are easy to use at the bedside in ICU or ward environments. The device will be zeroed and calibrated before each measurement.</offsets></p><p><offsets xml_i="25222" xml_f="25320" txt_i="14979" txt_f="15077">The method of determining fatigue resistance capacity is the protocol used by Chang and colleagues</offsets><xref ref-type="bibr" rid="b2"><offsets xml_i="25351" xml_f="25352" txt_i="15077" txt_f="15078">2</offsets></xref><offsets xml_i="25359" xml_f="25506" txt_i="15078" txt_f="15225"> and is based on the maximum incremental threshold loading test described in the American Thoracic Society/European Respiratory Society guidelines.</offsets><xref ref-type="bibr" rid="b23"><offsets xml_i="25538" xml_f="25540" txt_i="15225" txt_f="15227">23</offsets></xref><offsets xml_i="25547" xml_f="25913" txt_i="15227" txt_f="15593"> Following successful weaning from MV (ie, within 24–48 h), the patients' FRI is calculated. Following three MIP measurements (as above), subjects breathe through inspiratory resistance (through the Threshold IMT device) equivalent to 30% of the initial MIP for 2 min. This level of resistance that has been selected as the preliminary trials by Chang and colleagues</offsets><xref ref-type="bibr" rid="b2"><offsets xml_i="25944" xml_f="25945" txt_i="15593" txt_f="15594">2</offsets></xref><offsets xml_i="25952" xml_f="26568" txt_i="15594" txt_f="16201"> indicated that resistance equivalent to 50% of MIP resulted in severe dyspnoea. If the subject is not able to inspire at 30% of their MIP, no resistance is applied. MIP measurements are repeated at 2 min. During the loading task, the testing will be ceased if the rate of perceived exertion (RPE) is ≥7, pulse oximetric saturation falls &gt;10% from initial values or to &lt;90% or the heart rate increases by &gt;30 beats per minute. FRI is calculated comparing the preloading and postloading values of the MIP (ie, post-MIP/pre-MIP). The FRI procedure is repeated 7 days after successful weaning from ventilation.</offsets></p></sec><sec><title><offsets xml_i="26590" xml_f="26616" txt_i="16203" txt_f="16229">Cortisol and urea sampling</offsets></title><p><offsets xml_i="26627" xml_f="26817" txt_i="16230" txt_f="16420">Patients with an indwelling catheter in situ will have 24 h urine at baseline and day 7. Urine will be assayed for cortisol, creatinine and urea using high performance liquid chromatography.</offsets></p></sec><sec><title><offsets xml_i="26839" xml_f="26869" txt_i="16422" txt_f="16452">Dyspnoea (shortness of breath)</offsets></title><p><offsets xml_i="26880" xml_f="27060" txt_i="16453" txt_f="16633">Dyspnoea will be measured using a Modified Borg Scale (RPE categorical score out of 10), which has been found to have acceptable reliability and validity in patients undergoing MV.</offsets><xref ref-type="bibr" rid="b24"><offsets xml_i="27092" xml_f="27094" txt_i="16633" txt_f="16635">24</offsets></xref><offsets xml_i="27101" xml_f="27232" txt_i="16635" txt_f="16766"> RPE will be recorded both at rest and during exercise at successful weaning (24 h) and 1 week postweaning (by a blinded assessor).</offsets></p></sec><sec><title><offsets xml_i="27254" xml_f="27293" txt_i="16768" txt_f="16807">Quality of life and functional measures</offsets></title><p><offsets xml_i="27304" xml_f="27597" txt_i="16808" txt_f="17101">Quality of life is measured using the Short Form-36v2 tool (acute 1 week time frame) and the EQ-5D tool as one combined survey. The Short Form-36 tool has demonstrated reliability, responsiveness, construct and criterion validity and is responsive to clinical improvement in an ICU population.</offsets><xref ref-type="bibr" rid="b25"><offsets xml_i="27629" xml_f="27631" txt_i="17101" txt_f="17103">25</offsets></xref><offsets xml_i="27638" xml_f="27708" txt_i="17103" txt_f="17173"> The EQ-5D tool has also been used in intensive care patient follow-up</offsets><xref ref-type="bibr" rid="b26"><offsets xml_i="27740" xml_f="27742" txt_i="17173" txt_f="17175">26</offsets></xref><offsets xml_i="27749" xml_f="27911" txt_i="17175" txt_f="17337"> and is likely to give a more global measure of health-related quality of life. The survey will be completed on enrolment and 7 days following successful weaning.</offsets></p><p><offsets xml_i="27918" xml_f="28047" txt_i="17338" txt_f="17467">Functional level will be measured using the Acute Care Index of Function (ACIF), which has good levels of inter-rater reliability</offsets><xref ref-type="bibr" rid="b27"><offsets xml_i="28079" xml_f="28081" txt_i="17467" txt_f="17469">27</offsets></xref><offsets xml_i="28088" xml_f="28111" txt_i="17469" txt_f="17492"> and construct validity</offsets><xref ref-type="bibr" rid="b28"><offsets xml_i="28143" xml_f="28145" txt_i="17492" txt_f="17494">28</offsets></xref><offsets xml_i="28152" xml_f="28405" txt_i="17494" txt_f="17747"> in acute neurological conditions, however, has not been examined specifically in the ICU population. There are unpublished reports of the ACIF being used to measure functional recovery in ventilated patients and other non-neurological acute conditions.</offsets><xref ref-type="bibr" rid="b29"><offsets xml_i="28437" xml_f="28439" txt_i="17747" txt_f="17749">29</offsets></xref><offsets xml_i="28446" xml_f="28640" txt_i="17749" txt_f="17943"> In the absence of a more specific tool that has been validated for ICU patients, the construct validity of the ACIF renders it the most useful tool to measure functional recovery in this study.</offsets></p></sec></sec></sec><sec><title><offsets xml_i="28674" xml_f="28688" txt_i="17947" txt_f="17961">RCT2: overview</offsets></title><p><offsets xml_i="28699" xml_f="29152" txt_i="17962" txt_f="18415">This trial (RCT2) examines the effects of IMT on outcomes for patients who, for whatever reason, were unable to participate in IMT while still ventilator-dependent but have since weaned from ventilation within the previous 7 days and are now able to participate in training (eg, due to resolution of acute delirium, return of cardiovascular stability, etc). The outcomes of this trial will be analysed in relation to the findings of Chang and colleagues</offsets><xref ref-type="bibr" rid="b2"><offsets xml_i="29183" xml_f="29184" txt_i="18415" txt_f="18416">2</offsets></xref><offsets xml_i="29191" xml_f="29389" txt_i="18416" txt_f="18614"> that prolonged MV results in increased fatigability of inspiratory muscles following successful weaning from MV. Given that postweaning outcomes are often poor for patients undergoing prolonged MV,</offsets><xref ref-type="bibr" rid="b30"><offsets xml_i="29421" xml_f="29423" txt_i="18614" txt_f="18616">30</offsets></xref><offsets xml_i="29430" xml_f="29673" txt_i="18616" txt_f="18859"> evaluation of IMT as a method to ameliorate residual weakness, and thus accelerate rehabilitation, appears warranted. This trial was registered with the Australia New Zealand Clinical Trials Registry on 13 December 2010 (ACTRN12610001089022).</offsets></p><sec><title><offsets xml_i="29689" xml_f="29693" txt_i="18860" txt_f="18864">Aims</offsets></title><p><offsets xml_i="29704" xml_f="29748" txt_i="18865" txt_f="18909">RCT2 aims to answer the following questions:</offsets></p><list list-type="order"><list-item><p><offsets xml_i="29790" xml_f="29915" txt_i="18910" txt_f="19035">Does postweaning IMT affect residual inspiratory muscle strength or fatigability in patients ventilated for 7 days or longer?</offsets></p></list-item><list-item><p><offsets xml_i="29945" xml_f="30073" txt_i="19036" txt_f="19164">Does postweaning IMT affect dyspnoea levels, quality of life or functional recovery in patients ventilated for 7 days or longer?</offsets></p></list-item><list-item><p><offsets xml_i="30103" xml_f="30279" txt_i="19165" txt_f="19341">Does postweaning IMT result in lower rates of reintubation, readmission to ICU or duration of post-ICU hospital stay, in patients who have been ventilated for 7 days or longer?</offsets></p></list-item></list></sec><sec><title><offsets xml_i="30320" xml_f="30330" txt_i="19343" txt_f="19353">Hypotheses</offsets></title><p><offsets xml_i="30341" xml_f="30695" txt_i="19354" txt_f="19708">The hypotheses are that postweaning IMT will improve inspiratory muscle strength, reduce inspiratory muscle fatigability and dyspnoea and improve quality of life and functional measures in this population. Furthermore, it is hypothesised that IMT will result in a lower rate of reintubation and shorter post-ICU length of hospital stay in these patients.</offsets></p></sec><sec><title><offsets xml_i="30717" xml_f="30724" txt_i="19710" txt_f="19717">Methods</offsets></title><p><offsets xml_i="30735" xml_f="30862" txt_i="19718" txt_f="19845">RCT2 is a RCT with concealed allocation, blinded outcome assessors and intention-to-treat analysis. Refer to the second arm of </offsets><xref ref-type="fig" rid="fig1"><offsets xml_i="30894" xml_f="30902" txt_i="19845" txt_f="19853">figure 1</offsets></xref><offsets xml_i="30909" xml_f="30962" txt_i="19853" txt_f="19906"> regarding anticipated flow of patients through RCT2.</offsets></p><sec><title><offsets xml_i="30978" xml_f="30986" txt_i="19907" txt_f="19915">Subjects</offsets></title><p><offsets xml_i="30997" xml_f="31590" txt_i="19916" txt_f="20509">Subjects will be recruited from both Canberra Hospital and Calvary Hospital ICUs (both in Canberra, Australia). Patients who have recently weaned from MV in ICU (within previous 7 days, where the duration of ventilation was 7 or more days) will be recruited to RCT2, with automatic exclusion of patients included in RCT1. Suitable patients will be randomised (computer-generated randomisation sequence) to receive either IMT (in addition to usual physiotherapy care) or usual physiotherapy care only for 2 weeks postweaning. Usual physiotherapy care typically includes deep breathing exercises</offsets><xref ref-type="bibr" rid="b31"><offsets xml_i="31622" xml_f="31624" txt_i="20509" txt_f="20511">31</offsets></xref><offsets xml_i="31631" xml_f="31685" txt_i="20511" txt_f="20565"> (without a resistance device), assisted mobilisation,</offsets><xref ref-type="bibr" rid="b32"><offsets xml_i="31717" xml_f="31719" txt_i="20565" txt_f="20567">32</offsets></xref><offsets xml_i="31726" xml_f="31862" txt_i="20567" txt_f="20703"> secretion clearance techniques and upper and lower limb exercises as indicated. Treatment will occur in both ICU and ward environments.</offsets></p><p></p><sec><title><offsets xml_i="31885" xml_f="31903" txt_i="20705" txt_f="20723">Inclusion criteria</offsets></title><p><offsets xml_i="31914" xml_f="31964" txt_i="20724" txt_f="20774">All patients recently mechanically ventilated who:</offsets></p><list list-type="bullet"><list-item><p><offsets xml_i="32007" xml_f="32086" txt_i="20775" txt_f="20854">were ventilated for 7 days or longer and weaned from MV in the previous 7 days;</offsets></p></list-item><list-item><p><offsets xml_i="32116" xml_f="32135" txt_i="20855" txt_f="20874">are aged ≥16 years;</offsets></p></list-item><list-item><p><offsets xml_i="32165" xml_f="32231" txt_i="20875" txt_f="20941">are alert and able to co-operate with training (Riker score of 4);</offsets></p></list-item><list-item><p><offsets xml_i="32261" xml_f="32298" txt_i="20942" txt_f="20979">are able to provide informed consent.</offsets></p></list-item></list></sec><sec><title><offsets xml_i="32339" xml_f="32357" txt_i="20981" txt_f="20999">Exclusion criteria</offsets></title><p><offsets xml_i="32368" xml_f="32416" txt_i="21000" txt_f="21048">Patients will be excluded from RCT2 if they are:</offsets></p><list list-type="bullet"><list-item><p><offsets xml_i="32459" xml_f="32476" txt_i="21049" txt_f="21063">aged&lt;16 years;</offsets></p></list-item><list-item><p><offsets xml_i="32506" xml_f="32554" txt_i="21064" txt_f="21112">unwilling or unable to provide informed consent;</offsets></p></list-item><list-item><p><offsets xml_i="32584" xml_f="32612" txt_i="21113" txt_f="21141">previously included in RCT1;</offsets></p></list-item><list-item><p><offsets xml_i="32642" xml_f="32651" txt_i="21142" txt_f="21151">pregnant;</offsets></p></list-item><list-item><p><offsets xml_i="32681" xml_f="32716" txt_i="21152" txt_f="21184">mechanically ventilated &lt;7 days;</offsets></p></list-item><list-item><p><offsets xml_i="32746" xml_f="32824" txt_i="21185" txt_f="21257">not alert or able to co-operate with training (Riker score of &lt;4 or &gt;4);</offsets></p></list-item><list-item><p><offsets xml_i="32854" xml_f="33031" txt_i="21258" txt_f="21435">experiencing significant pain that interferes with breathing capacity (eg, fractured ribs): IMT could be reconsidered when pain is controlled and patient is able to participate;</offsets></p></list-item><list-item><p><offsets xml_i="33061" xml_f="33114" txt_i="21436" txt_f="21489">medically unstable or deemed suitable for palliation.</offsets></p></list-item></list></sec></sec><sec><title><offsets xml_i="33161" xml_f="33177" txt_i="21492" txt_f="21508">Outcome measures</offsets></title><p><xref ref-type="table" rid="tbl1"><offsets xml_i="33222" xml_f="33229" txt_i="21509" txt_f="21516">Table 1</offsets></xref><offsets xml_i="33236" xml_f="33293" txt_i="21516" txt_f="21573"> provides a summary of the outcome measures used in RCT2.</offsets></p></sec></sec><sec><title><offsets xml_i="33321" xml_f="33354" txt_i="21576" txt_f="21609">Interventions, samples and assays</offsets></title><p><offsets xml_i="33365" xml_f="33906" txt_i="21610" txt_f="22148">Refer to RCT1 for details of the Threshold IMT device and training parameters. The only difference for RCT2 is that there will be no return to MV between sets, rather the patient is rested (either on room air or oxygen) as appropriate. As per the previous description, the training session will be directly supervised by the physiotherapist and should take &lt;10 min/day. Training will occur on weekdays from enrolment until 2 weeks later. All other outcome measures will be conducted as previously described in the time frames outlined in </offsets><xref ref-type="table" rid="tbl1"><offsets xml_i="33940" xml_f="33947" txt_i="22148" txt_f="22155">table 1</offsets></xref><offsets xml_i="33954" xml_f="33955" txt_i="22155" txt_f="22156">.</offsets></p></sec></sec><sec><title><offsets xml_i="33983" xml_f="34003" txt_i="22159" txt_f="22179">Termination criteria</offsets></title><p><offsets xml_i="34014" xml_f="34536" txt_i="22180" txt_f="22702">An individual would be withdrawn from the study in the case of death, withdrawal of consent or ability to participate actively. Should a patient in the view of the treating physician not tolerate the intervention, for whatever reason, the patient may be withdrawn from the study; however, follow-up data including FRI would still be collected and all data collected will be analysed on an intention-to-treat basis. Adverse outcomes are not anticipated, due to the demonstrated safety of the technique in our own pilot data</offsets><xref ref-type="bibr" rid="b12"><offsets xml_i="34568" xml_f="34570" txt_i="22702" txt_f="22704">12</offsets></xref><offsets xml_i="34577" xml_f="34639" txt_i="22704" txt_f="22766"> and the lack of documented adverse sequelae in other studies.</offsets><xref ref-type="bibr" rid="b7"><offsets xml_i="34670" xml_f="34671" txt_i="22766" txt_f="22767">7</offsets></xref><offsets xml_i="34678" xml_f="34679" txt_i="22767" txt_f="22768">
</offsets><xref ref-type="bibr" rid="b8"><offsets xml_i="34710" xml_f="34711" txt_i="22768" txt_f="22769">8</offsets></xref><offsets xml_i="34718" xml_f="34719" txt_i="22769" txt_f="22770">
</offsets><xref ref-type="bibr" rid="b10"><offsets xml_i="34751" xml_f="34753" txt_i="22770" txt_f="22772">10</offsets></xref><offsets xml_i="34760" xml_f="34761" txt_i="22772" txt_f="22773">
</offsets><xref ref-type="bibr" rid="b11"><offsets xml_i="34793" xml_f="34795" txt_i="22773" txt_f="22775">11</offsets></xref></p><p><offsets xml_i="34809" xml_f="34898" txt_i="22776" txt_f="22865">According to a recent multisite study on the safety of physiotherapy intervention in ICU,</offsets><xref ref-type="bibr" rid="b33"><offsets xml_i="34930" xml_f="34932" txt_i="22865" txt_f="22867">33</offsets></xref><offsets xml_i="34939" xml_f="35588" txt_i="22867" txt_f="23498"> the following criteria would cause the treating therapist to cease the intervention immediately and alert on-site medical attention (ie, senior ICU registrar): alteration in blood pressure &gt; or &lt;20% resting, alteration in heart rate &lt; or &gt;20% resting, new arrhythmia, oxygen desaturation &gt;10%, pulmonary artery pressure (systolic) &gt;60 mm Hg, suspected pneumothorax and agitation risking detachment of equipment or lines or requiring increase sedation. Should such an episode occur, the participant's suitability for remaining in the trial would be reviewed by the chief investigator, in consultation with senior ICU medical staff.</offsets></p></sec><sec><title><offsets xml_i="35610" xml_f="35625" txt_i="23500" txt_f="23515">Minimising bias</offsets></title><p><offsets xml_i="35636" xml_f="35754" txt_i="23516" txt_f="23634">Outcome measures will be taken by blinded assessors; however, therapists providing the intervention cannot be blinded.</offsets></p><p><offsets xml_i="35761" xml_f="36071" txt_i="23635" txt_f="23945">Patients will be informed that the study is investigating different types of ‘breathing exercises’, without reference to a device, thus allowing blinding of the patients. Although a sham comparison would be ideal, most sham interventions with the threshold device have used low training pressures (eg, 9–11 cmH</offsets><sub><offsets xml_i="36076" xml_f="36077" txt_i="23945" txt_f="23946">2</offsets></sub><offsets xml_i="36083" xml_f="36201" txt_i="23946" txt_f="24064">O). The concern is that for the weakest patients, this level of training can be challenging. In our pilot case series,</offsets><xref ref-type="bibr" rid="b12"><offsets xml_i="36233" xml_f="36235" txt_i="24064" txt_f="24066">12</offsets></xref><offsets xml_i="36242" xml_f="36316" txt_i="24066" txt_f="24140"> several subjects trained for several sessions with pressures below 15 cmH</offsets><sub><offsets xml_i="36321" xml_f="36322" txt_i="24140" txt_f="24141">2</offsets></sub><offsets xml_i="36328" xml_f="36437" txt_i="24141" txt_f="24247">O pressure, generating RPE scores of &gt;7. Our observations are also substantiated by the work of De Jonghe </offsets><italic><offsets xml_i="36445" xml_f="36450" txt_i="24247" txt_f="24252">et al</offsets></italic><xref ref-type="bibr" rid="b3"><offsets xml_i="36490" xml_f="36491" txt_i="24252" txt_f="24253">3</offsets></xref><offsets xml_i="36498" xml_f="36613" txt_i="24253" txt_f="24368"> who were able to quantify the median MIP for ventilated patients who have returned to consciousness as only 30 cmH</offsets><sub><offsets xml_i="36618" xml_f="36619" txt_i="24368" txt_f="24369">2</offsets></sub><offsets xml_i="36625" xml_f="36649" txt_i="24369" txt_f="24393">O. That is, a mere 9 cmH</offsets><sub><offsets xml_i="36654" xml_f="36655" txt_i="24393" txt_f="24394">2</offsets></sub><offsets xml_i="36661" xml_f="36817" txt_i="24394" txt_f="24550">O training pressure would equate to 30% of MIP, and 30% intensity has shown training benefits in patients with chronic obstructive pulmonary disease (COPD).</offsets><xref ref-type="bibr" rid="b34 b35 b36"><offsets xml_i="36857" xml_f="36862" txt_i="24550" txt_f="24555">34–36</offsets></xref><offsets xml_i="36869" xml_f="37215" txt_i="24555" txt_f="24901"> Thus, it would be difficult to use a true sham without risking inadvertent ‘training’ of the weakest patients. As an alternative to a true ‘sham’ comparison, the control subjects will receive daily coached breathing exercises (deep breathing or demand ventilation exercises without a threshold device) to minimise the potential Hawthorne effect.</offsets></p></sec><sec><title><offsets xml_i="37237" xml_f="37270" txt_i="24903" txt_f="24936">Proposed methods of data analysis</offsets></title><p><offsets xml_i="37281" xml_f="37595" txt_i="24937" txt_f="25251">Data will be analysed using both an intention-to-treat and per-protocol analysis with a carry forward analysis for missing data. Mean changes scores, SDs and 95% CIs will be calculated between groups for preintervention and postintervention. It is anticipated that the analysis will use a combination of t tests, χ</offsets><sup><offsets xml_i="37600" xml_f="37601" txt_i="25251" txt_f="25252">2</offsets></sup><offsets xml_i="37607" xml_f="38112" txt_i="25252" txt_f="25757"> tests and repeated measures analysis of variance (or non-parametric equivalents) as appropriate. If missing data is a problem, a mixed model may be used. There will be a baseline comparison of age, gender, Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, highest Sequential Organ Failure Assessment (SOFA) score and length of stay. There will be a priori stratification of those subjects with known neuromuscular disease (eg, Guillain–Barre, motor neuron disease, myasthenia gravis).</offsets></p><sec><title><offsets xml_i="38128" xml_f="38148" txt_i="25758" txt_f="25778">Predictive modelling</offsets></title><p><offsets xml_i="38159" xml_f="38233" txt_i="25779" txt_f="25853">A substudy of RCT1 will analyse the correlation between IMT pressures (cmH</offsets><sub><offsets xml_i="38238" xml_f="38239" txt_i="25853" txt_f="25854">2</offsets></sub><offsets xml_i="38245" xml_f="38392" txt_i="25854" txt_f="26001">O) and duration of weaning (hours off ventilator in a 24 h period). If possible a mathematical model linking these two variables will be described.</offsets></p></sec><sec><title><offsets xml_i="38414" xml_f="38427" txt_i="26003" txt_f="26016">Contingencies</offsets></title><p><offsets xml_i="38438" xml_f="38622" txt_i="26017" txt_f="26201">Should subject recruitment prove slow to reach the required sample size for this study, the study duration may be increased by 6–12 months as required, pending ongoing ethics approval.</offsets></p></sec><sec><title><offsets xml_i="38644" xml_f="38659" txt_i="26203" txt_f="26218">Data management</offsets></title><p><offsets xml_i="38670" xml_f="39137" txt_i="26219" txt_f="26686">A custom-designed database will store deidentified patient data in a secure password-protected file accessible only to designated research office staff. Data will be entered by blinded research office staff from hard copies, which are stored in a locked office. Data completeness will be reviewed by research office staff quarterly and cross-referenced with existing medical records. The investigators will only have access to the database on completion of the study.</offsets></p></sec></sec><sec><title><offsets xml_i="39165" xml_f="39190" txt_i="26689" txt_f="26714">Concomitant interventions</offsets></title><p><offsets xml_i="39201" xml_f="39326" txt_i="26715" txt_f="26840">All usual physiotherapy interventions, including early mobilisation as is the standard of care in both ICUs, will be allowed.</offsets></p><p><offsets xml_i="39333" xml_f="39476" txt_i="26841" txt_f="26984">No specific medical or surgical interventions are disallowed for trial participants other than those described in the exclusion criteria above.</offsets></p></sec><sec><title><offsets xml_i="39498" xml_f="39522" txt_i="26986" txt_f="27010">Ethics and dissemination</offsets></title><p><offsets xml_i="39533" xml_f="39622" txt_i="27011" txt_f="27100">Ethics approval has been gained for these studies through three institutional committees:</offsets></p><list list-type="order"><list-item><p><offsets xml_i="39664" xml_f="39748" txt_i="27101" txt_f="27185">Australian Capital Territory Health Human Research Ethics Committee (ETH 10.10.370).</offsets></p></list-item><list-item><p><offsets xml_i="39778" xml_f="39827" txt_i="27186" txt_f="27235">Calvary Hospital Human Research Ethics Committee.</offsets></p></list-item><list-item><p><offsets xml_i="39857" xml_f="39929" txt_i="27236" txt_f="27308">University of Queensland Medical Research Ethics Committee (2010001488).</offsets></p></list-item></list><p><offsets xml_i="39955" xml_f="40125" txt_i="27309" txt_f="27479">Any adverse events connected with the trial would be immediately reported to all three committees above as well as registered through the hospital risk management system.</offsets></p><p><offsets xml_i="40132" xml_f="40363" txt_i="27480" txt_f="27711">The results of this study will be presented at national and international intensive care and physiotherapy conferences and will be submitted for publication in peer-reviewed journals particularly focused on intensive care medicine.</offsets></p></sec><sec><title><offsets xml_i="40385" xml_f="40395" txt_i="27713" txt_f="27723">Discussion</offsets></title><p><offsets xml_i="40406" xml_f="40911" txt_i="27724" txt_f="28229">The findings of this study would be highly relevant to intensive care staff who address the challenges of ventilatory weaning and physical rehabilitation. Any intervention that can hasten weaning from MV, or recovery following ICU stay, is highly likely to reduce overall length of stay and may reduce associated morbidity and mortality. In addition to the individual patient benefits that this will produce, there is a potential for a substantial community economic benefit due to reduced hospital costs.</offsets></p><p><offsets xml_i="40918" xml_f="41320" txt_i="28230" txt_f="28632">If efficacy of IMT can be demonstrated, this could lead to a change in intensive care practice internationally across disciplines, including physiotherapy, respiratory therapy, nursing and intensive care medicine. Ultimately, the people most likely to benefit from this study are the patients, with improved understanding of methods to optimise treatment and minimise the complications of prolonged MV.</offsets></p></sec><sec sec-type="supplementary-material"><title><offsets xml_i="41376" xml_f="41398" txt_i="28634" txt_f="28656">Supplementary Material</offsets></title><supplementary-material id="d33e166" content-type="local-data"><caption><title><offsets xml_i="41485" xml_f="41504" txt_i="28657" txt_f="28676">Author's manuscript</offsets></title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="bmjopen-2012-000813.draft_revisions.pdf"></media></supplementary-material><supplementary-material id="d33e167" content-type="local-data"><caption><title><offsets xml_i="41736" xml_f="41753" txt_i="28677" txt_f="28694">Reviewer comments</offsets></title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="bmjopen-2012-000813.reviewer_comments.pdf"></media></supplementary-material></sec></body><back><fn-group><fn fn-type="other"><p><bold>To cite:</bold> Bissett BM, Leditschke IA, Paratz JD, <italic>et al</italic>. Protocol: inspiratory muscle training for promoting recovery and outcomes in ventilated patients (IMPROVe): a randomised controlled trial. <italic>BMJ Open</italic> 2012;<bold>2</bold>:e000813. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmjopen-2012-000813">10.1136/bmjopen-2012-000813</ext-link></p></fn><fn fn-type="participating-researchers"><p><bold>Contributors:</bold> BMB: research, contribution of original material, editing and approval of final manuscript. IAL: research, research supervision, contribution of original material, editing and approval of final manuscript. JDP: research, research supervision, contribution of original material, editing and approval of final manuscript. RB: research supervision, contribution of original material and approval of final manuscript.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold>
This study is funded by the <funding-source>Canberra Hospital Private Practice Fund</funding-source> and the <funding-source>Canberra Hospital Auxiliary Scholarship</funding-source>. Neither committees have any influence on study design, collection or analysis of data, or publication of results. These remain the sole prerogative of the investigators.</p></fn><fn fn-type="conflict"><p><bold>Competing interests:</bold> None.</p></fn><fn fn-type="other"><p><bold>Patient consent:</bold> Obtained.</p></fn><fn fn-type="other"><p><bold>Ethics approval:</bold> Ethics approval was provided by Australian Capital Territory Health Human Research Ethics Committee and Calvary Hospital Human Research Ethics Committee and University of Queensland Medical Human Research Committee.</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Data sharing statement:</bold> No additional data available.</p></fn></fn-group><ref-list><title>References</title><ref id="b1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobin</surname><given-names>MJ</given-names></name><name><surname>Laghi</surname><given-names>F</given-names></name><name><surname>Jubran</surname><given-names>A</given-names></name></person-group>
<article-title>Narrative review: ventilator-induced respiratory muscle weakness</article-title>. <source>Ann Intern Med</source>
<year>2010</year>;<volume>153</volume>:<fpage>240</fpage>–<lpage>5</lpage><pub-id pub-id-type="pmid">20713792</pub-id></mixed-citation></ref><ref id="b2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>AT</given-names></name><name><surname>Boots</surname><given-names>RJ</given-names></name><name><surname>Brown</surname><given-names>MG</given-names></name><etal></etal></person-group>
<article-title>Reduced inspiratory muscle endurance following successful weaning from prolonged mechanical ventilation</article-title>. <source>Chest</source>
<year>2005</year>;<volume>128</volume>:<fpage>553</fpage>–<lpage>9</lpage><pub-id pub-id-type="pmid">16100137</pub-id></mixed-citation></ref><ref id="b3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jonghe</surname><given-names>B</given-names></name><name><surname>Bastuji-Garin</surname><given-names>S</given-names></name><name><surname>Durand</surname><given-names>MC</given-names></name><etal></etal></person-group>
<article-title>Respiratory weakness is associated with limb weakness and delayed weaning in critical illness</article-title>. <source>Crit Care Med</source>
<year>2007</year>;<volume>35</volume>:<fpage>2007</fpage>–<lpage>15</lpage><pub-id pub-id-type="pmid">17855814</pub-id></mixed-citation></ref><ref id="b4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Taylor</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans</article-title>. <source>N Engl J Med</source>
<year>2008</year>;<volume>358</volume>:<fpage>1327</fpage>–<lpage>35</lpage><pub-id pub-id-type="pmid">18367735</pub-id></mixed-citation></ref><ref id="b5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bissett</surname><given-names>B</given-names></name><name><surname>Leditschke</surname><given-names>IA</given-names></name><name><surname>Paratz</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Respiratory dysfunction in ventilated patients: can inspiratory muscle training help? A review</article-title>. <source>Anaesth Intensive Care</source>. <year>2012</year>;<volume>40</volume> In press.</mixed-citation></ref><ref id="b6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoemaker</surname><given-names>MJ</given-names></name><name><surname>Donker</surname><given-names>S</given-names></name><name><surname>Lapoe</surname><given-names>A</given-names></name></person-group>
<article-title>Inspiratory muscle training in patients with chronic obstructive pulmonary disease: the state of the evidence</article-title>. <source>Cardiopulm Phys Ther J</source>
<year>2009</year>;<volume>20</volume>:<fpage>5</fpage>–<lpage>15</lpage><pub-id pub-id-type="pmid">20467518</pub-id></mixed-citation></ref><ref id="b7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sprague</surname><given-names>SS</given-names></name><name><surname>Hopkins</surname><given-names>PD</given-names></name></person-group>
<article-title>Use of inspiratory strength training to wean six patients who were ventilator-dependent</article-title>. <source>Phys Ther</source>
<year>2003</year>;<volume>83</volume>:<fpage>171</fpage>–<lpage>81</lpage><pub-id pub-id-type="pmid">12564952</pub-id></mixed-citation></ref><ref id="b8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>AD</given-names></name><name><surname>Davenport</surname><given-names>PD</given-names></name><name><surname>Franceschi</surname><given-names>AC</given-names></name><etal></etal></person-group>
<article-title>Use of inspiratory muscle strength training to facilitate ventilator weaning: a series of 10 consecutive patients</article-title>. <source>Chest</source>
<year>2002</year>;<volume>122</volume>:<fpage>192</fpage>–<lpage>6</lpage><pub-id pub-id-type="pmid">12114357</pub-id></mixed-citation></ref><ref id="b9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bissett</surname><given-names>B</given-names></name><name><surname>Leditschke</surname><given-names>IA</given-names></name></person-group>
<article-title>Inspiratory muscle training to enhance weaning from mechanical ventilation</article-title>. <source>Anaesth Intensive Care</source>
<year>2007</year>;<volume>35</volume>:<fpage>776</fpage>–<lpage>9</lpage><pub-id pub-id-type="pmid">17933168</pub-id></mixed-citation></ref><ref id="b10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cader</surname><given-names>SA</given-names></name><name><surname>Vale</surname><given-names>RG</given-names></name><name><surname>Castro</surname><given-names>JC</given-names></name><etal></etal></person-group>
<article-title>Inspiratory muscle training improves maximal inspiratory pressure and may assist weaning in older intubated patients: a randomised trial</article-title>. <source>J Physiother</source>
<year>2010</year>;<volume>56</volume>:<fpage>171</fpage>–<lpage>7</lpage><pub-id pub-id-type="pmid">20795923</pub-id></mixed-citation></ref><ref id="b11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>AD</given-names></name><name><surname>Smith</surname><given-names>BK</given-names></name><name><surname>Davenport</surname><given-names>PD</given-names></name><etal></etal></person-group>
<article-title>Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial</article-title>. <source>Crit Care</source>
<year>2011</year>;<volume>15</volume>:<fpage>R84</fpage><pub-id pub-id-type="pmid">21385346</pub-id></mixed-citation></ref><ref id="b12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bissett</surname><given-names>B</given-names></name><name><surname>Leditschke</surname><given-names>IA</given-names></name><name><surname>Green</surname><given-names>M</given-names></name></person-group>
<article-title>Specific inspiratory muscle training is safe in selected patients who are ventilator-dependent: a case series</article-title>. <source>Intensive Crit Care Nurs</source>
<year>2012</year> doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.iccn.2012.01.003">10.1016/j.iccn.2012.01.003</ext-link></mixed-citation></ref><ref id="b13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witt</surname><given-names>JD</given-names></name><name><surname>Guenette</surname><given-names>JA</given-names></name><name><surname>Rupert</surname><given-names>JL</given-names></name><etal></etal></person-group>
<article-title>Inspiratory muscle training attenuates the human respiratory muscle metaboreflex</article-title>. <source>J Physiol</source>
<year>2007</year>;<volume>584</volume>:<fpage>1019</fpage>–<lpage>28</lpage><pub-id pub-id-type="pmid">17855758</pub-id></mixed-citation></ref><ref id="b14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riker</surname><given-names>RR</given-names></name><name><surname>Picard</surname><given-names>JT</given-names></name><name><surname>Fraser</surname><given-names>GL</given-names></name></person-group>
<article-title>Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients</article-title>. <source>Crit Care Med</source>
<year>1999</year>;<volume>27</volume>:<fpage>1325</fpage>–<lpage>9</lpage><pub-id pub-id-type="pmid">10446827</pub-id></mixed-citation></ref><ref id="b15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blattner</surname><given-names>C</given-names></name><name><surname>Guaragna</surname><given-names>JC</given-names></name><name><surname>Saadi</surname><given-names>E</given-names></name></person-group>
<article-title>Oxygenation and static compliance is improved immediately after early manual hyperinflation following myocardial revascularisation: a randomised controlled trial</article-title>. <source>Aust J Physiother</source>
<year>2008</year>;<volume>54</volume>:<fpage>173</fpage>–<lpage>8</lpage><pub-id pub-id-type="pmid">18721120</pub-id></mixed-citation></ref><ref id="b16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweickert</surname><given-names>WD</given-names></name><name><surname>Pohlman</surname><given-names>MC</given-names></name><name><surname>Pohlman</surname><given-names>AS</given-names></name><etal></etal></person-group>
<article-title>Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial</article-title>. <source>Lancet</source>
<year>2009</year>;<volume>373</volume>:<fpage>1874</fpage>–<lpage>82</lpage><pub-id pub-id-type="pmid">19446324</pub-id></mixed-citation></ref><ref id="b17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>PE</given-names></name><name><surname>Goad</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Early intensive care unit mobility therapy in the treatment of acute respiratory failure</article-title>. <source>Crit Care Med</source>
<year>2008</year>;<volume>36</volume>:<fpage>2238</fpage>–<lpage>43</lpage><pub-id pub-id-type="pmid">18596631</pub-id></mixed-citation></ref><ref id="b18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gosselink</surname><given-names>R</given-names></name><name><surname>Wagenaar</surname><given-names>RC</given-names></name><name><surname>Decramer</surname><given-names>M</given-names></name></person-group>
<article-title>Reliability of a commercially available threshold loading device in healthy subjects and in patients with chronic obstructive pulmonary disease</article-title>. <source>Thorax</source>
<year>1996</year>;<volume>51</volume>:<fpage>601</fpage>–<lpage>5</lpage><pub-id pub-id-type="pmid">8693441</pub-id></mixed-citation></ref><ref id="b19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>K</given-names></name><name><surname>Cecins</surname><given-names>NM</given-names></name><name><surname>Eastwood</surname><given-names>PR</given-names></name><etal></etal></person-group>
<article-title>Inspiratory muscle training for patients with chronic obstructive pulmonary disease: a practical guide for clinicians</article-title>. <source>Arch Phys Med Rehabil</source>
<year>2010</year>;<volume>91</volume>:<fpage>1466</fpage>–<lpage>70</lpage><pub-id pub-id-type="pmid">20801269</pub-id></mixed-citation></ref><ref id="b20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>K</given-names></name><name><surname>Jenkins</surname><given-names>SC</given-names></name><name><surname>Philippe</surname><given-names>DL</given-names></name><etal></etal></person-group>
<article-title>High-intensity inspiratory muscle training in COPD</article-title>. <source>Eur Respir J</source>
<year>2006</year>;<volume>27</volume>:<fpage>1119</fpage>–<lpage>28</lpage><pub-id pub-id-type="pmid">16772388</pub-id></mixed-citation></ref><ref id="b21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>M</given-names></name><name><surname>Road</surname><given-names>J</given-names></name><name><surname>Sieck</surname><given-names>G</given-names></name><etal></etal></person-group>; <collab>Tests of respiratory muscle strength</collab>
<article-title>ATS/ERS Statement on respiratory muscle testing</article-title>. <source>Am J Respir Crit Care Med</source>
<year>2002</year>;<volume>166</volume>:<fpage>528</fpage>–<lpage>47</lpage><pub-id pub-id-type="pmid">12456380</pub-id></mixed-citation></ref><ref id="b22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamnegard</surname><given-names>CH</given-names></name><name><surname>Wragg</surname><given-names>S</given-names></name><name><surname>Kyroussis</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Portable measurement of maximum mouth pressures</article-title>. <source>Eur Respir J</source>
<year>1994</year>;<volume>7</volume>:<fpage>398</fpage>–<lpage>401</lpage><pub-id pub-id-type="pmid">8162993</pub-id></mixed-citation></ref><ref id="b23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clanton</surname><given-names>T</given-names></name><name><surname>Calverly</surname><given-names>P</given-names></name><name><surname>Celli</surname><given-names>B</given-names></name></person-group>
<article-title>Tests of respiratory muscle endurance. ATS / ERS statement on respiratory muscle testing</article-title>. <source>Am J Respir Crit Care Med</source>
<year>2002</year>;<volume>166</volume>:<fpage>559</fpage>–<lpage>70</lpage></mixed-citation></ref><ref id="b24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>J</given-names></name><name><surname>Bennett</surname><given-names>SJ</given-names></name></person-group>
<article-title>Measurement of dyspnea in patients treated with mechanical ventilation</article-title>. <source>Am J Crit Care</source>
<year>1999</year>;<volume>8</volume>:<fpage>254</fpage>–<lpage>61</lpage><pub-id pub-id-type="pmid">10392226</pub-id></mixed-citation></ref><ref id="b25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>JA</given-names></name><name><surname>Black</surname><given-names>NA</given-names></name><name><surname>Jenkinson</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Outcome measures for adult critical care: a systematic review</article-title>. <source>Health Technol Assess</source>
<year>2000</year>;<volume>4</volume>:<fpage>1</fpage>–<lpage>111</lpage><pub-id pub-id-type="pmid">11074394</pub-id></mixed-citation></ref><ref id="b26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granja</surname><given-names>C</given-names></name><name><surname>Morujao</surname><given-names>E</given-names></name><name><surname>Costa-Pereira</surname><given-names>A</given-names></name></person-group>
<article-title>Quality of life in acute respiratory distress syndrome survivors may be no worst than in other ICU survivors</article-title>. <source>Intensive Care Med</source>
<year>2003</year>;<volume>29</volume>:<fpage>1744</fpage>–<lpage>50</lpage><pub-id pub-id-type="pmid">12774161</pub-id></mixed-citation></ref><ref id="b27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dillen</surname><given-names>LR</given-names></name><name><surname>Roach</surname><given-names>KE</given-names></name></person-group>
<article-title>Reliability and validity of the Acute Care Index of Function for patients with neurologic impairment</article-title>. <source>Phys Ther</source>
<year>1988</year>;<volume>68</volume>:<fpage>1098</fpage>–<lpage>101</lpage><pub-id pub-id-type="pmid">3387465</pub-id></mixed-citation></ref><ref id="b28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roach</surname><given-names>KE</given-names></name><name><surname>Van Dillen</surname><given-names>LR</given-names></name></person-group>
<article-title>Development of an Acute Care Index of Functional status for patients with neurologic impairment</article-title>. <source>Phys Ther</source>
<year>1988</year>;<volume>68</volume>:<fpage>1102</fpage>–<lpage>8</lpage><pub-id pub-id-type="pmid">3387466</pub-id></mixed-citation></ref><ref id="b29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherer</surname><given-names>SA</given-names></name><name><surname>Hammerich</surname><given-names>AS</given-names></name></person-group>
<article-title>Outcomes in cardiopulmonary physical therapy: acute care index of function</article-title>. <source>Cardiopulm Phys Ther J</source>
<year>2008</year>;<volume>19</volume>:<fpage>94</fpage>–<lpage>7</lpage><pub-id pub-id-type="pmid">20467504</pub-id></mixed-citation></ref><ref id="b30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>SL</given-names></name><name><surname>Daly</surname><given-names>BJ</given-names></name><name><surname>Gordon</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Survival and quality of life: short-term versus long-term ventilator patients</article-title>. <source>Crit Care Med</source>
<year>2002</year>;<volume>30</volume>:<fpage>2655</fpage>–<lpage>62</lpage><pub-id pub-id-type="pmid">12483055</pub-id></mixed-citation></ref><ref id="b31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westerdahl</surname><given-names>E</given-names></name><name><surname>Lindmark</surname><given-names>B</given-names></name><name><surname>Eriksson</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Deep-breathing exercises reduce atelectasis and improve pulmonary function after coronary artery bypass surgery</article-title>. <source>Chest</source>
<year>2005</year>;<volume>128</volume>:<fpage>3482</fpage>–<lpage>8</lpage><pub-id pub-id-type="pmid">16304303</pub-id></mixed-citation></ref><ref id="b32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>MR</given-names></name><name><surname>Ellis</surname><given-names>E</given-names></name><name><surname>Johnston</surname><given-names>C</given-names></name></person-group>
<article-title>Randomised clinical trial of physiotherapy after open abdominal surgery in high risk patients</article-title>. <source>Aust J Physiother</source>
<year>2005</year>;<volume>51</volume>:<fpage>151</fpage>–<lpage>9</lpage><pub-id pub-id-type="pmid">16137240</pub-id></mixed-citation></ref><ref id="b33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeppos</surname><given-names>L</given-names></name><name><surname>Patman</surname><given-names>S</given-names></name><name><surname>Berney</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Physiotherapy in intensive care is safe: an observational study</article-title>. <source>Aust J Physiother</source>
<year>2007</year>;<volume>53</volume>:<fpage>279</fpage>–<lpage>83</lpage><pub-id pub-id-type="pmid">18047463</pub-id></mixed-citation></ref><ref id="b34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preusser</surname><given-names>BA</given-names></name><name><surname>Winningham</surname><given-names>ML</given-names></name><name><surname>Clanton</surname><given-names>TL</given-names></name></person-group>
<article-title>High- vs low-intensity inspiratory muscle interval training in patients with COPD</article-title>. <source>Chest</source>
<year>1994</year>;<volume>106</volume>:<fpage>110</fpage>–<lpage>17</lpage><pub-id pub-id-type="pmid">8020255</pub-id></mixed-citation></ref><ref id="b35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lisboa</surname><given-names>C</given-names></name><name><surname>Munoz</surname><given-names>V</given-names></name><name><surname>Beroiza</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads with a threshold device</article-title>. <source>Eur Respir J</source>
<year>1994</year>;<volume>7</volume>:<fpage>1266</fpage>–<lpage>74</lpage><pub-id pub-id-type="pmid">7925905</pub-id></mixed-citation></ref><ref id="b36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez Riera</surname><given-names>H</given-names></name><name><surname>Montemayor Rubio</surname><given-names>T</given-names></name><name><surname>Ortega Ruiz</surname><given-names>F</given-names></name><etal></etal></person-group>
<article-title>Inspiratory muscle training in patients with COPD: effect on dyspnea, exercise performance, and quality of life</article-title>. <source>Chest</source>
<year>2001</year>;<volume>120</volume>:<fpage>748</fpage>–<lpage>56</lpage><pub-id pub-id-type="pmid">11555505</pub-id></mixed-citation></ref></ref-list></back></article>